471 related articles for article (PubMed ID: 31932090)
21. [Efficacy and safety of intravitreal dexamethasone implant in diabetic macular edema patients with and without prior vitrectomy: a retrospective cohort study].
Li LY; Li J; Li Y; Zhang W; Wang DY; Wang WL; Liang BY; Gu W
Zhonghua Yan Ke Za Zhi; 2023 May; 59(5):398-403. PubMed ID: 37151009
[No Abstract] [Full Text] [Related]
22. DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.
Iglicki M; Busch C; Zur D; Okada M; Mariussi M; Chhablani JK; Cebeci Z; Fraser-Bell S; Chaikitmongkol V; Couturier A; Giancipoli E; Lupidi M; Rodríguez-Valdés PJ; Rehak M; Fung AT; Goldstein M; Loewenstein A
Retina; 2019 Jan; 39(1):44-51. PubMed ID: 29697589
[TBL] [Abstract][Full Text] [Related]
23. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.
Arıkan Yorgun M; Toklu Y; Mutlu M
Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study.
Mathis T; Lereuil T; Abukashabah A; Voirin N; Sudhalkar A; Bilgic A; Denis P; Dot C; Kodjikian L
Acta Diabetol; 2020 Dec; 57(12):1413-1421. PubMed ID: 32656710
[TBL] [Abstract][Full Text] [Related]
25. Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.
Mahapatra SK; Kumari S
Indian J Ophthalmol; 2020 Mar; 68(3):490-493. PubMed ID: 32057010
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema.
Zucchiatti I; Lattanzio R; Querques G; Querques L; Del Turco C; Cascavilla ML; Bandello F
Ophthalmologica; 2012; 228(2):117-22. PubMed ID: 22310491
[TBL] [Abstract][Full Text] [Related]
27. Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema.
Matonti F; Pommier S; Meyer F; Hajjar C; Merite PY; Parrat E; Rouhette H; Rebollo O; Guigou S
Eur J Ophthalmol; 2016 Aug; 26(5):454-9. PubMed ID: 27079207
[TBL] [Abstract][Full Text] [Related]
28. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema.
Callanan DG; Gupta S; Boyer DS; Ciulla TA; Singer MA; Kuppermann BD; Liu CC; Li XY; Hollander DA; Schiffman RM; Whitcup SM;
Ophthalmology; 2013 Sep; 120(9):1843-51. PubMed ID: 23706947
[TBL] [Abstract][Full Text] [Related]
29. Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
Pessoa B; Coelho J; Correia N; Ferreira N; Beirão M; Meireles A
Ophthalmic Res; 2018; 59(2):68-75. PubMed ID: 29248913
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes.
Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş
Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587
[TBL] [Abstract][Full Text] [Related]
31. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM;
BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345
[TBL] [Abstract][Full Text] [Related]
32. Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome.
Al-Khersan H; Hariprasad SM; Chhablani J;
Am J Ophthalmol; 2017 Dec; 184():121-128. PubMed ID: 29032109
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal Dexamethasone Implant in the Treatment of Diabetic Macular Edema Focusing.
Mudroch T; Hrevuš M; Karhanová M; Řehák J; Marešová K
Cesk Slov Oftalmol; 2024; 80(Ahead of print):1-8. PubMed ID: 38925895
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of single-dose dexamethasone implantation in patients with persistent diabetic macular edema.
Arıkan Yorgun M; Toklu Y; Mutlu M; Uysal BS; Çakmak HB
Int Ophthalmol; 2016 Aug; 36(4):531-9. PubMed ID: 26644130
[TBL] [Abstract][Full Text] [Related]
35. Effect of dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes of Taiwanese patients with treatment-naïve diabetic macular edema.
Wang JK; Huang TL; Chang PY
J Formos Med Assoc; 2020 Nov; 119(11):1619-1625. PubMed ID: 32482606
[TBL] [Abstract][Full Text] [Related]
36. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
[TBL] [Abstract][Full Text] [Related]
37. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
38. Rapid response to dexamethasone intravitreal implant in diabetic macular edema.
Lo Giudice G; Avarello A; Campana G; Galan A
Eur J Ophthalmol; 2018 Jan; 28(1):74-79. PubMed ID: 28708221
[TBL] [Abstract][Full Text] [Related]
39. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.
Cicinelli MV; Cavalleri M; Querques L; Rabiolo A; Bandello F; Querques G
Br J Ophthalmol; 2017 Dec; 101(12):1689-1693. PubMed ID: 28432109
[TBL] [Abstract][Full Text] [Related]
40. [Multicenter Ozurdex® assessment for diabetic macular edema: MOZART study].
Guigou S; Hajjar C; Parrat E; Merite PY; Pommier S; Matonti F; Prost-Magnin O; Meyer F
J Fr Ophtalmol; 2014 Jun; 37(6):480-5. PubMed ID: 24813119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
